Making every sample count
”Hemolysis is a major issue for the ER, and point-of-care detection of hemolysis significantly improves patient care and reduces our work load”
Every year, millions of blood samples worldwide are discarded and cannot be analyzed due to hemolysis.
hemCheck is developing a simple, yet sophisticated product addressing the issue of hemolyzed blood samples. The product is a fast and reliable point of care test, ensuring the quality of every sample taken. Saving lives, reducing costs and improving health care quality. Making every sample count.
Hemcheck Sweden AB (hemCheck) is a public medical technology company based in Karlstad, Sweden. hemcheck is listed on Nasdaq First North Stockholm. hemCheck was founded in 2010 based on an invention by Dr. Mathias Karlsson.
Investerardagen in Stockholm August 28, 2017
New project, new collaboration, and a new opportunity to make a difference. In partnership with a researcher from Karolinska Institutet, HemCheck will investigate the incidence of hemolysis in blood gas analyses. Read more...
hemCheck, a medical technology company addressing the issue of hemolysis, announces results from user tests at Karlstad Central Hospital, where nurses used a prototype of hemCheck’s point of care test in a clinical setting. The user tests confirmed that hemolysis is a...
hemCheck Publishes the Annual Report for 2016 - Regulatory This Press Release should not be released or distributed, directly or indirectly, within USA, Canada, Japan, Australia, Hong Kong, Switzerland, Singapore, South Africa, New Zealand or any other jurisdictions...
Read more >> (Only in Swedish)
Many interesting meetings today at Company mingle, Karolinska institute. Internship projects for postdocs and early career researchers. For more information visit:...
To Vårdfocus (Only in Swedish) >>